Loading
Latest filing published 17 Aug 2026 for SANOFI, €1.1M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Roy PAPATHEODOROU discloses dealings in Sanofi to AMF. In total, 3 filings cover trades dated from 25 May 2026 to 14 August 2026.
No open-market purchase appears, only 2 sales worth €1.2M. Other entries cover 1 share grant.
The newest entry dates from 17 August 2026: an open-market sale of €1.1M, in Sanofi. Typically, a trade is published a median of 3 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations